Frequency of nonaspirin NSAID-relevant coexisting medical conditions in the primary-care setting: a retrospective database review

References

• RuiPOkeyodeTNational Ambulatory Medical Survey: 2015 state and national summary tables Available from: https://www.cdc.gov/nchs/data/ahcd/namcs_summary/2015_namcs_web_tables.pdfAccessed January 14, 2019
   Google Scholar
• CDCNational Center for Health Statistics. Summary health statistics: NHIS2016 Available from: https://ftp.cdc.gov/pub/Health_Statistics/NCHS/NHIS/SHS/2016_SHS_Table_A-4.pdfAccessed January 14, 2019
   Google Scholar
• HochbergMCAltmanRDAprilKTAmerican College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and kneeArthritis Care Res2012644465474
   PubMed Web of Science ®Google Scholar
• McalindonTEBannuruRRSullivanMCOARSI guidelines for the non-surgical management of knee osteoarthritisOsteoarthritis Cartilage201422336338824462672
   PubMed Web of Science ®Google Scholar
• KatzJNSmithSRCollinsJECost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbiditiesOsteoarthritis Cartilage201624340941826525846
   PubMed Web of Science ®Google Scholar
• By the American Geriatrics Society 2015 Beers Criteria Update Expert PanelAmerican Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adultsJ Am Geriatr Soc201563112227224626446832
   PubMed Web of Science ®Google Scholar
• United States Department of Health and Human ServicesFood and Drug Administration. Organ-specific warnings; internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final monograph; technical amendment11252009 Available from: https://www.federalregister.gov/documents/2009/11/25/E9-28296/organ-specific-warnings-internal-analgesic-antipyretic-and-antirheumatic-drug-products-forAccessed January 13, 2019
   Google Scholar
• ScaglioneSKliethermesSCaoGThe epidemiology of cirrhosis in the United States: a population-based studyJ Clin Gastroenterol201549869069625291348
   PubMed Web of Science ®Google Scholar
• BallyMDendukuriNRichBRisk of acute myocardial infarction with NSAIDs in real world use: Bayesian meta-analysis of individual patient dataBMJ2017357j190928487435
   PubMed Web of Science ®Google Scholar
• McGettiganPHenryDCardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studiesPLoS Med201189e100109821980265
   PubMed Web of Science ®Google Scholar
• Coxib and traditional NSAID Trialists’ (CNT) CollaborationBhalaNEmbersonJVascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trialsLancet2013382989476977923726390
   PubMed Web of Science ®Google Scholar
• TrelleSReichenbachSWandelSCardiovascular safety of non-steroidal anti-inflammatory drugs: Network meta-analysisBMJ20113421c708621224324
   PubMed Web of Science ®Google Scholar
• CastellsagueJRiera-GuardiaNCalingaertBOn behalf of the Investigators of the safety of non-steroidal anti-inflammatory drugs (SOS) projectDrug Safety201235121127114623137151
   PubMed Web of Science ®Google Scholar
• WilcoxCMCryerBTriadafilopoulosGPatterns of use and public perception of OTC pain relievers: focus on NSAIDsJ Rheumatol200532112218222416265706
   PubMed Web of Science ®Google Scholar
• HannaLAHughesCMPublic’s views on making decisions about over-the-counter medication and their attitudes towards evidence of effectiveness: a cross-sectional questionnaire studyPatient Educ Couns201183334535121440405
   PubMed Web of Science ®Google Scholar
• BoudreauDMWirtzHvon KorffMCatzSLSt JohnJStangPEA survey of adult awareness and use of medicine containing acetaminophenPharmacoepidemiol Drug Saf201322322924022890688
   PubMed Web of Science ®Google Scholar
• JangSMCerulliJGrabeDWNSAID-avoidance education in community pharmacies for patients at high risk for acute kidney injury, upstate New York, 2011Prev Chronic Dis20141111E22025523351
   PubMed Web of Science ®Google Scholar
• HenrichWLAgodoaLEBarrettBAnalgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the National Kidney FoundationAm J Kidney Dis19962711621658546133
   PubMed Web of Science ®Google Scholar
• MatthewsMLThe role of dose reduction with NSAID useAm J Manag Care20131914 SupplS273S27724494606
   PubMed Web of Science ®Google Scholar
• BruneKPatrignaniPNew insights into the use of currently available non-steroidal anti-inflammatory drugsJ Pain Res2015810511825759598
   PubMed Web of Science ®Google Scholar
• PaiABDivineHMarciniakMNational Kidney Disease Education Program Pharmacy Working Group. Need for a judicious use of nonsteroidal anti-inflammatory drugs to avoid community-acquired acute kidney injuryAnn Pharmacother201811060028018789174
   Google Scholar
• MearaASSimonLSAdvice from professional societies: appropriate use of NSAIDsPain Med201314suppl 1S3S1024373108
   PubMed Web of Science ®Google Scholar
• American Geriatrics Society Expert Panel on the Care of Older Adults with MultimorbidityGuiding principles for the care of older adults with multimorbidity: an approach for cliniciansJ Am Geriatr Soc20126010E1E2522994865
   PubMed Web of Science ®Google Scholar
• LanzaFLChanFKQuigleyEMPractice Parameters Committee of the American College of GastroenterologyGuidelines for prevention of NSAID-related ulcer complicationsAm J Gastroenterol2009104372873819240698
   PubMed Web of Science ®Google Scholar
• TaylorRLemtouniSWeissKPergolizziJVPain management in the elderly: an FDA Safe Use Initiative Expert Panel’s view on preventable harm associated with NSAID therapyCurr Gerontol Geriatr Res20122012719
   Google Scholar
• American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older PersonsPharmacological management of persistent pain in older personsJ Am Geriatr Soc20095781331134619573219
   PubMed Web of Science ®Google Scholar
• ZhangWDohertyMArdenNEULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)Ann Rheum Dis200564566968115471891
   PubMed Web of Science ®Google Scholar
• JordanKMArdenNKDohertyMEULAR 2003 evidence based recommendations for the management of knee osteoarthritis ESCISITAnn Rheum Dis2003621145115514644851
   PubMed Web of Science ®Google Scholar
• ZhangWNukiGMoskowitzRWOARSI recommendations for the management of hip and knee osteoarthritis: Part III: changes in evidence following systematic cumulative update of research published through January 2009Osteoarthritis Cartilage201018447649920170770
   PubMed Web of Science ®Google Scholar
• RichettePDohertyMPascualE2016 updated EULAR evidence-based recommendations for the management of goutAnn Rheum Dis2017761294227457514
   PubMed Web of Science ®Google Scholar
• KhannaDKhannaPPFitzgeraldJD2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritisArthritis Care Res2012641014471461
   PubMed Web of Science ®Google Scholar
• FDADrug Safety Availability. FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes https://www.fda.gov/Drugs/DrugSafety/ucm451800.htmAccessed January 14, 2019
   Google Scholar
• FDA U.S. Postmarket drug safety information for patients and providersIbuprofen Drug Facts label Available from: https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsand-Providers/ucm125225.htmAccessed January 14, 2019
   Google Scholar